Lsv Asset Management Acadia Pharmaceuticals Inc Transaction History
Lsv Asset Management
- $41.9 Billion
- Q2 2025
A detailed history of Lsv Asset Management transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Lsv Asset Management holds 210,000 shares of ACAD stock, worth $4.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
210,000
Previous 76,241
175.44%
Holding current value
$4.4 Million
Previous $1.27 Million
257.74%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
348Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$898 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$253 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$188 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$129 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.39B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...